Log in or Sign up for Free to view tailored content for your specialty!
Thyroid News
Patients prefer combined therapy for hypothyroidism, but data reveal few added benefits
BOSTON — Most adults with hypothyroidism prefer combination therapy with liothyronine plus levothyroxine over levothyroxine alone, but most trials find combination therapy provides limited added benefit, according to two speakers.
EDC exposures for reproductive-aged women tied to socioeconomic status
BOSTON — Pregnant and reproductive-aged women have had recent declines in exposure to most endocrine-disrupting chemicals, though women with a lower socioeconomic status are exposed to higher chemical levels, according to a speaker.
Log in or Sign up for Free to view tailored content for your specialty!
Cognitive decline with hypoparathyroidism linked to changes in brain structure
Adults with hypoparathyroidism experience declines in cognitive function that may be due to structural changes in the brain, according to findings published in the Journal of Bone and Mineral Research.
New vitamin D consensus guideline, debates highlight ENDO annual meeting
Endocrinology providers and researchers will gather in Boston beginning Saturday as the Endocrine Society holds its 2024 annual meeting.
VIDEO: How endocrinologists can navigate social media
NEW ORLEANS — In this video exclusive, Jonathan D. Leffert, MD, talks with Arti Bhan, MD, FACE, and Cheryl Rosenfeld, DO, FACE, FACP, FSVM, ECNUFC, about building a social media presence and talking with patients about social media hype.
New guidance, technology on the horizon for thyroid nodule risk assessment
NEW ORLEANS —New risk stratification guidance for classifying thyroid nodules may come soon as imaging technology continues to evolve, according to a speaker at the AACE annual meeting.
AI, new technology major focus at 2024 AACE annual meeting
Looking to the future will be a key theme at the American Association of Clinical Endocrinology 2024 annual meeting with a keynote lecture focused on AI and sessions examining guidance updates and new technology.
Subclinical hypothyroidism less likely for men with higher dietary vitamin E intake
Men who consumed more dietary vitamin E may be less likely to develop subclinical hypothyroidism and autoimmune thyroiditis, though no associations were observed among women, according to findings published in Thyroid.
GLP-1 receptor agonist tied to similar thyroid cancer risk as DPP-IV, SGLT2 inhibitors
Adults who initiate a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those prescribed a DPP-IV inhibitor or an SGLT2 inhibitor, according to study findings published in The BMJ.
FDA fast tracks PTH1 receptor agonist for treatment of hypoparathyroidism
The FDA granted fast track designation for an investigational parathyroid hormone 1 receptor agonist to treat hypoparathyroidism, according to an industry press release.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read